Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $54.4B | $53.8B | $56.9B | $64.9B | $77.2B | $83.1B | $92.9B | $106B | $118B | $130B |
| Revenue growth | — | -1.1% | 5.8% | 14.0% | 18.9% | 7.7% | 11.8% | 14.5% | 10.7% | 10.1% |
| Operating income | $1.74B | $4.26B | $3.10B | $3.19B | $4.99B | $3.15B | $3.80B | $4.01B | $2.56B | $2.70B |
| Operating margin | 3.2% | 7.9% | 5.4% | 4.9% | 6.5% | 3.8% | 4.1% | 3.8% | 2.2% | 2.1% |
| Net income | $614M | $2.45B | $1.68B | $2.71B | $3.37B | $2.93B | $2.81B | $2.49B | $1.21B | $1.19B |
| Net margin | 1.1% | 4.6% | 3.0% | 4.2% | 4.4% | 3.5% | 3.0% | 2.3% | 1.0% | 0.9% |
| EPS (diluted) | $4.07 | $16.81 | $12.16 | $20.10 | $25.31 | $22.67 | $22.08 | $20.00 | $9.98 | $9.84 |
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $1.94B | $4.05B | $2.17B | $5.28B | $5.64B | $2.26B | $4.59B | $3.98B | $2.97B | $921M |
| Capital expenditures | $527M | $524M | $612M | $736M | $964M | $1.34B | $1.14B | $1.00B | $575M | $546M |
| Free cash flow | $1.41B | $3.53B | $1.56B | $4.55B | $4.67B | $920M | $3.45B | $2.98B | $2.39B | $375M |
| Share buybacks | $104M | $3.37B | $1.09B | $1.07B | $1.82B | $79.0M | $2.10B | $1.57B | $817M | $151M |
| Dividends paid | $177M | $220M | $265M | $291M | $323M | $354M | $392M | $431M | $431M | $430M |
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $3.88B | $4.04B | $2.34B | $4.05B | $4.67B | $3.39B | $5.06B | $4.69B | $2.22B | $4.20B |
| Total assets | $25.4B | $27.2B | $25.4B | $29.1B | $35.0B | $44.4B | $43.1B | $47.1B | $46.5B | $48.9B |
| Total liabilities | $14.7B | $17.3B | $15.3B | $17.0B | $21.2B | $28.3B | $27.7B | $30.7B | $30.0B | $31.2B |
| Long-term debt | $3.79B | $4.77B | $4.38B | $4.97B | $6.06B | $10.5B | $9.03B | $10.2B | $11.1B | $12.4B |
| Shareholders' equity | $10.7B | $9.84B | $10.2B | $12.0B | $13.7B | $16.1B | $15.3B | $16.3B | $16.4B | $17.7B |
| Retained earnings | $11.5B | $13.7B | $15.1B | $17.5B | $20.5B | $23.1B | $25.5B | $27.5B | $28.3B | $29.1B |
| Shares (wtd avg diluted) | 151M | 146M | 138M | 135M | 133M | 129M | 127M | 124M | 121M | 121M |
Every figure is extracted from HUMANA INC’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.